Volume: 30 Issue: 3

1. Advances in the treatment of children with acute promyelocytic leukemia Page:161—164
2. Advances in pathogenesis of children with chronic refractory immune thrombocytopenia Page:164—167
3. Recent advances of treatment in children with retinoblastoma Page:167—171
4. Central nervous system complications after hematopoietic stem cell transplantation Page:172—175
5. Effect of nutritional support on therapy-related side effects in acute lymphoblastic leukemia children undergoing chemotherapy Page:176—179
6. Relationship between SLCO1B1 521T > C genovariation and severe toxicity during high-dose methotrexate chemotherapy Page:184—188
7. Effect of Atorvastatin on apoptosis of HL-60 leukemic cells via the regulation of the phosphatidylinositol 3-kinase/serine/threonine protein kinase/mammalian target of rapamycin signaling pathway Page:198—202
8. Comparative analysis of clinical characteristics of immune thrombocytopenia in children with different ages Page:203—206
9. Correlation analysis of positive myeloid antigen and clinical feature of children with acute lymphoblastic leukemia Page:211—215
10. Preparation of leukemia cell vaccine expressing Bacille Calmette-Guérin heat shock protein 70 and its anti-leukemia therapeutic effect Page:216—220
11. The latest treatment advances of severe acquired aplastic anemia Page:236—238
12. Clinical characteristics and clinical observation of granulocyte sarcoma in children Page:180—183
13. Evaluation of the efficacy of immunosuppressive therapy with rabbit-antithymocyte globulin combined with Cyclosporine in children with severe aplastic anemia Page:189—193
14. Expressions of pro-apoptotic protein Smac and HtrA2 in children with acute leukemia and its clinical significance Page:207—210
15. A case report of childhood hepatosplenic γδT cell lymphoma and literature review Page:221—223
16. Reversal effect study of vitamin D on leukemia multidrug resistance cells Page:229—232
17. Effects and mechanisms of matrine on proliferation and apoptosis of human rhabdomyosarcoma RD cells line Page:233—235